Stay updated on Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial
Sign up to get notified when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.

Latest updates to the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page
- Check3 days agoChange DetectedThe study record history shows new entries for Study Design and Study Status, indicating updates to the trial's design and its current status. An older history entry dated 2026-05-28 was removed.SummaryDifference0.2%

- Check10 days agoChange DetectedA new revision label v3.6.5 was added to the history, representing the latest page revision. This update supersedes the previous v3.6.4.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe revision history adds a new entry for Revision: v3.6.4, replacing the previous Revision: v3.6.3. This reflects a minor update to the page's version rather than a change to study data or content.SummaryDifference0.0%

- Check46 days agoChange DetectedThe history records a new site revision (v3.6.3) being added and the previous v3.6.2 removed. This represents a small software update to the page rather than changes to trial details or records.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a small system update. No study data or navigation elements appear to be affected.SummaryDifference0.0%

- Check68 days agoChange DetectedThe record history now adds 'No longer looking for participants' and updates the revision to v3.6.0. This indicates a new version of the study record and that enrollment has ended.SummaryDifference0.2%

Stay in the know with updates to Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.